Skip to main content

EDITORIAL article

Front. Cell. Infect. Microbiol., 02 February 2024
Sec. Virus and Host
This article is part of the Research Topic Bunyaviruses - threats to health and economy View all 6 articles

Editorial: Bunyaviruses - threats to health and economy

  • 1Department of Microbiology, School of Preclinical Medicine, Airforce Medical University (Fourth Military Medical University), Xi’an, Shaanxi, China
  • 2Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, Jilin, China

Editorial on the Research Topic
Bunyaviruses - threats to health and economy

Previously, Bunyaviridae, which was upgraded to Bunyavirales after the 10th International Committee on Taxonomy of Viruses (ICTV) (Maes et al., 2018). Under the new virus taxonomy system, the arenaviridae has also been included in the bunyavirales, which means that bunyaviruses contain the most diverse pathogenic viruses that are detrimental to both animals and plants (Maes et al., 2018). The increase in global human activity and rapid urbanization has increased the possibility of human contact with wildlife. Most bunyaviruses originate from zoonotic diseases, and outbreaks may result in significant loss of life, economic contraction, and social instability.

In this Research Topic, Chen et al. generalized the current status of the development of three highly pathogenic bunyavirus vaccines, with a focus on Crimean–Congo hemorrhagic fever virus, Rift alley fever Virus (RVFV), and Hantaan Virus (HTNV), characterized by Nairoviridae, Phenuiviridae, and Hantaviridae, respectively. At present, in addition to the HFRS inactivated vaccine used in East Asia, CCHFV inactivated vaccines are derived from mouse brains and used in Bulgaria, but there are no other vaccines available for human use against Bunyaviruses. This review summarizes the current status of vectored-, subunit-, and DNA-vaccine development and proposes new directions for these viruses, including improved subunit vaccines and mRNA-LNP-based vaccines.

RVF is an arboviral disease that is transmitted mainly through mosquito bites. Since its discovery in the Great Rift Valley of East Africa, the prevalence of RVFV has been continuously expanding, with the most noteworthy being the outbreak in Egypt in 1977 and its entry into the Arabian Peninsula in 2001 (Linthicum et al., 2016). The research conducted by Bron et al. focused on the transmission dynamics of RVFV infection in natural hosts through artificial reconstruction. They found that lambs infected with RVFV required more bites to ensure viremia, and a peak in viral load occurred 2-4 days after biting. Their results indicate that the likelihood of a successful infection in ruminant hosts is influenced by the number of infectious mosquito bites, with an estimated transmission efficiency of 28% (95% confidence interval: 15-47%) for each bite. The results of using mathematical models to simulate RVFV outbreaks in lambs (i.e., R0>1) indicate the required host-to-mosquito ratio and provide a reference for proposing targeted prevention strategies in the future.

In addition to epidemiology, from a molecular biology perspective, the replication and assembly of a virus itself are extremely important for maintaining its life cycle. In this Research Topic, Tercero et al. found multiple viral RNA binding sites within Gn via UV-crosslinking and immunoprecipitation followed by high-throughput sequencing analysis (CLIP-seq analysis). These modifications are important for the efficient packaging of antigenomic S RNA into virions. Among these sites, one located in the 3’ noncoding region was important for the ability of the virus to suppress interferon-β signaling. These findings suggest the important role of the interaction between viral RNA and structural glycoproteins in the RVFV life cycle.

Severe fever with thrombocytopenia syndrome virus (SFTSV), a newly discovered tick-borne bunyavirus, has attracted increased amounts of attention because of its high mortality rate of more than 40% (Li et al., 2021). In the recent ICTV category, SFTSV was named Dabie bandavirus (DBV) of the Bandavirus genus within the Phenuiviridae family (Sasaya et al., 2023). In this study, Song et al. retrospectively analyzed the clinical outcomes of SFTSV-infected patients under co-infected conditions. They found that, out of 157 infected patients, 43 patients with co - infections had a higher mortality rate compared to 114 non - co - infected patients did (P=0.011). Therefore, appropriate treatment strategies are needed to prevent co infections, and strengthened monitoring and timely and appropriate treatment are needed to minimize mortality rates.

Although bunyaviruses cause severe diseases in humans, the specific pathogenic mechanism involved is largely unknown. In addition to direct virus-induced injury, immunological injury is considered to play an important role in bunyavirus infection-directed pathogenesis (Brocato and Hooper, 2019). Among these bunyaviruses, hantavirus infection does not cause an obvious cytopathic effect, and cytotoxic T lymphocyte responses have been shown to play a role in hantavirus-induced diseases (Noack et al., 2020). In this Research Topic, Zhang et al. revealed that during Hantaan virus (HTNV) infection, CD8+ T cells were bystander activated after HTNV infection in HFRS patients and may be involved in host injury. Mechanistically, HTNV-infected endothelial cells produced high levels of IL-15, which was positively correlated with disease severity and the expression of NKG2D on bystander-activated CD8+ T cells. Moreover, elevated IL-15 could induce the activation of IL-15Rβ+NKG2D+ bystander CD8+ T cells. The expression of IL-15Rα and its ligand NKG2D was upregulated in HTNV-infected endothelial cells. Bystander-activated CD8+ T cells can exert cytotoxic effects on endothelial cells, which can be enhanced by IL-15 stimulation and blocked by an NKG2D antibody. Therefore, the IL-15/NKG2D axis could serve as an important pathway for bystander activation of memory CD8+ T cells, which may be a possible mechanism for the pathogenesis of HFRS. However, whether the IL15/NKG2D axis contributes to bystander activation of CD8+ T cells in other human viral diseases and whether IL-15 or NKG2D could be considered therapeutic targets in the treatment of the immunopathology of viral diseases are questions worth exploring in the future.

Although the above articles in the Research Topic provide new interesting information on bunyaviruses, specific treatment choices, preventive vaccines and pathogenic mechanisms for these highly pathogenic viruses still need further investigation. In addition, epidemiological research and replication mechanisms may aid in antiviral development and herd management strategy optimization.

Author contributions

WY: Writing – original draft, Writing – review & editing, Visualization. FY: Writing – review & editing, Supervision, Visualization.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Brocato, R. L., Hooper, J. W. (2019). Progress on the prevention and treatment of hantavirus disease. Viruses 11 (7), 610. doi: 10.3390/v11070610

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, J., Li, S., Yang, L., Cao, P., Lu, J. (2021). Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus. Crit. Rev. Microbiol. 47, 112–125. doi: 10.1080/1040841X.2020.1847037

PubMed Abstract | CrossRef Full Text | Google Scholar

Linthicum, K. J., Britch, S. C., Anyamba, A. (2016). Rift valley fever: an emerging mosquito-borne disease. Annu. Rev. Entomol. 61, 395–415. doi: 10.1146/annurev-ento-010715-023819

PubMed Abstract | CrossRef Full Text | Google Scholar

Maes, P., Alkhovsky, S. V., Bao, Y., Beer, M., Birkhead, M., Briese, T., et al. (2018). et al: Taxonomy of the family Arenaviridae and the order Bunyavirales: update 2018. Arch. Virol. 163 (8), 2295–2310. doi: 10.1007/s00705-018-3843-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Noack, D., Goeijenbier, M., Reusken, C., Koopmans, M. P. G., Rockx, B. H. G. (2020). Orthohantavirus pathogenesis and cell tropism. Front. Cell Infect. Microbiol. 10, 399. doi: 10.3389/fcimb.2020.00399

PubMed Abstract | CrossRef Full Text | Google Scholar

Sasaya, T., Palacios, G., Briese, T., Di Serio, F., Groschup, M. H., Neriya, Y., et al. (2023). ICTV virus taxonomy profile: Phenuiviridae 2023. J. Gen. Virol. 104 (9). doi: 10.1099/jgv.0.001893

CrossRef Full Text | Google Scholar

Keywords: Bunyavirales, Hantaviridae, Phenuiviridae, Nairoviridae, Dabie bandavirus (DBV), severe fever with thrombocytopenia syndrome virus (SFTSV), Rift Valley fever virus (RVFV), Crimean–Congo hemorrhagic fever virus (CCHFV)

Citation: Ye W and Yan F (2024) Editorial: Bunyaviruses - threats to health and economy. Front. Cell. Infect. Microbiol. 14:1369530. doi: 10.3389/fcimb.2024.1369530

Received: 12 January 2024; Accepted: 25 January 2024;
Published: 02 February 2024.

Edited and Reviewed by:

John Hiscott, Istituto Pasteur Italia Cenci Bolognetti Foundation, Italy

Copyright © 2024 Ye and Yan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Wei Ye, virologyyw@fmmu.edu.cn; Feihu Yan, yanfh1990@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.